Concepedia

Author

Manish Khanolkar

University of AucklandORCID

Also Known As

Khanolkar, Manish, M Khanolkar, M. Khanolkar, M.P. Khanolkar, Manish Khanolkar, Manish P. Khanolkar

33

Publications

5.4K

Citations

15

H-Index

26

Concepts

All Affiliations

University of AucklandGreenlane Clinical CentreWaitemata District Health BoardAuckland District Health BoardDeakin University
MK

About

Manish Khanolkar is an author at University of Auckland specializing in diabetes, metabolic syndrome, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

3.5K

2

Diabetes

4

4

3.5K

3

Health Sciences

2

2

91

4

Public Health

1

1

2.8K

5

Biochemistry

1

1

45

Manish Khanolkar

×

13

Publications

4.9K

Citations

12

H-Index

YearCitations

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais,

The Lancet

2019

2.8K

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

S. J. Creely, Philip G. McTernan, Christine M. Kusminski,

American Journal of Physiology-Endocrinology and Metabolism

2006

1K

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais,

The Lancet

2019

600

Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial

Rosie Dobson, Robyn Whittaker, Yannan Jiang,

BMJ

2018

162

Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus—An effect probably mediated by direct platelet PPARγ activation

Manish Khanolkar, R.H. Morris, Andrew W. Thomas,

Atherosclerosis

2007

46

Visfatin Is Regulated by Rosiglitazone in Type 2 Diabetes Mellitus and Influenced by NFκB and JNK in Human Abdominal Subcutaneous Adipocytes

Kirsty McGee, Alison L. Harte, Nancy F. da Silva,

PLoS ONE

2011

45

Risk factors for recurrent admissions with diabetic ketoacidosis: a case–control observational study

Howard Cooper, Amelia Tekiteki, Manish Khanolkar,

Diabetic Medicine

2015

41

Text message-based diabetes self-management support (SMS4BG): study protocol for a randomised controlled trial

Rosie Dobson, Robyn Whittaker, Yannan Jiang,

Trials

2016

38

The Use of Mobile Health to Deliver Self-Management Support to Young People With Type 1 Diabetes: A Cross-Sectional Survey

Rosie Dobson, Robyn Whittaker, Rinki Murphy,

JMIR Diabetes

2017

35

Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes

Ted Wu, Bryan Betty, Michelle Downie,

Diabetes Therapy

2015

33

Page 1